Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection

Coronavirus disease 2019 (COVID-19) has had devastating effects worldwide, with particularly high morbidity and mortality in outbreaks on residential care facilities. Amantadine, originally licensed as an antiviral agent for therapy and prophylaxis against influenza A virus, has beneficial effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sun-Young, Guo, Zhiru, Liu, Ping, McKay, Lindsay G. A., Storm, Nadia, Griffiths, Anthony, Qu, Ming Da, Finberg, Robert W., Somasundaran, Mohan, Wang, Jennifer P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238102/
https://www.ncbi.nlm.nih.gov/pubmed/37274537
http://dx.doi.org/10.3390/covid2110111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238102/
https://www.ncbi.nlm.nih.gov/pubmed/37274537
http://dx.doi.org/10.3390/covid2110111

Ejemplares similares